FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Franck bonnetain

Research Profile

Concepts & Ideas

Procedures

Chemicals & Drugs

Disorders

Co-author Network

Publications

TOP 3
Séverine Guiu; Laurent Arnould; Franck bonnetain; Charles Coutant; Gilles CREHANGE; Cécile Dalban; Isabelle Desmoulins; Laure Favier; Pierre Fumoleau; Bruno Coudert
Pathological response and survival after neoadjuvant therapy for breast cancer: A 30-year study.
Aziz Zaanan; Franck bonnetain; Pierre Laurent-Puig; Franck A Sinicrope; Julien Taïeb
Colon cancer mutation: prognosis/prediction--letter.
Momar Diouf; Thomas Filleron; Loïc Fin; Xavier Paoletti; Carl Picard; Jean-Claude Barbare; Olivier Bouché; Laetitia Dahan; Franck bonnetain
The added value of quality of life (QoL) for prognosis of overall survival in patients with palliative hepatocellular carcinoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Franck bonnetain (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Séverine Guiu; Laurent Arnould; Franck bonnetain; Charles Coutant; Gilles CREHANGE; Cécile Dalban; Isabelle Desmoulins; Laure Favier; Pierre Fumoleau; Bruno Coudert
Pathological response and survival after neoadjuvant therapy for breast cancer: A 30-year study.
Breast (Edinburgh, Scotland) 2013;22(3):301-8.
2013: Aziz Zaanan; Franck bonnetain; Pierre Laurent-Puig; Franck A Sinicrope; Julien Taïeb
Colon cancer mutation: prognosis/prediction--letter.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013;19(5):1300.
2013: Momar Diouf; Thomas Filleron; Loïc Fin; Xavier Paoletti; Carl Picard; Jean-Claude Barbare; Olivier Bouché; Laetitia Dahan; Franck bonnetain
The added value of quality of life (QoL) for prognosis of overall survival in patients with palliative hepatocellular carcinoma.
Journal of hepatology 2013;58(3):509-21.
2013: Carine A Bellera; Anne Auperin; Laurence Collette; Tienhan Sandrine Dabakuyo; Adélaïde Doussau; Thomas Filleron; Catherine Fortpied; Sophie Gourgou; Andrew Kramar; Christophe Le Tourneau; Simone Mathoulin-Pélissier; Murielle Mauer; Monia Ouali; Xavier Paoletti; Marina Pulido; Franck bonnetain
Protocol of the Definition for the Assessment of Time-to-event Endpoints in CANcer trials (DATECAN) project: formal consensus method for the development of guidelines for standardised time-to-event endpoints' definitions in cancer clinical trials.
European journal of cancer (Oxford, England : 1990) 2013;49(4):769-81.
2013: Christine Rotonda; Michel Velten; Franck bonnetain; Francis Guillemin; Thierry Conroy
Factors associated with fatigue after surgery in women with early-stage invasive breast cancer.
The oncologist 2013;18(4):467-75.
2013: Aziz Zaanan; Nicolas Williet; Valérie Boige; Franck bonnetain; Stéphane Cattan; Tienhan Sandrine Dabakuyo; Olivier Dubreuil; Laetitia Fartoux; Mohamed Hebbar; Touraj Mansourbakht; Olivier Rosmorduc; Julien Taïeb
Gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma: a large multicenter AGEO study.
Journal of hepatology 2013;58(1):81-8.
2012: I Le Ray; P Maingon; L Arnould; P Arveux; M Bardou; S Causeret; B Coudert; Gilles CREHANGE; S Dabakuyo; J Fraisse; P Fumoleau; Franck bonnetain
Neoadjuvant therapy for breast cancer has no benefits on overall survival or on the mastectomy rate in routine clinical practice. A population-based study with a median follow-up of 11 years using propensity score matching.
European journal of cancer (Oxford, England : 1990) 2012;48(15):2300-10.
2012: Sylvain Ladoire; C Levy; A Lortholary; C Mesleard; Grégoire Mignot; F Penault-Llorca; Cédric Rébé; H Roché; M Spielmann; Lionel Apetoh; Laurent Arnould; Romain Boidot; Franck bonnetain; A Chevriaux; Cécile Dalban; F Eichler; Pierre Fumoleau; François Ghiringhelli
FOXP3 expression in cancer cells and anthracyclines efficacy in patients with primary breast cancer treated with adjuvant chemotherapy in the phase III UNICANCER-PACS 01 trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(10):2552-61.
2012: Christophe Tournigand; Thierry André; Jean-Baptiste Bachet; Corrado Boni; Franck bonnetain; Benoist Chibaudel; Tamas Hickish; Gérard Lledo; Josep Tabernero; Luis Teixeira; Aimery de Gramont
Adjuvant therapy with fluorouracil and oxaliplatin in stage II and elderly patients (between ages 70 and 75 years) with colon cancer: subgroup analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(27):3353-60.
2012: Cindy Neuzillet; Eric Raymond; Vinciane Rebours; Benoît Rousseau; Philippe Ruszniewski; Léïla Bengrine-Lefèvre; Franck bonnetain; Olivia Hentic; Philippe Lévy; Christophe Louvet; Pascal Hammel
FOLFIRI regimen in metastatic pancreatic adenocarcinoma resistant to gemcitabine and platinum-salts.
World journal of gastroenterology : WJG 2012;18(33):4533-41.
2012: Isabelle Le Ray; Laurent Azoulay; Franck bonnetain; Sophie Dell'Aniello; Samy Suissa
Local estrogen therapy and risk of breast cancer recurrence among hormone-treated patients: a nested case-control study.
Breast cancer research and treatment 2012;135(2):603-9.
2012: J B Bachet; A Bardier-Dupas; Franck bonnetain; J Closset; A Couvelard; P Demetter; J F Emile; P Hammel; C Louvet; R Maréchal; François Paye; C Penna; P Rougier; I Salmon; A Sauvanet; Magali Svrcek; J C Vaillant; T André; J L Van Laethem
Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in resected pancreatic adenocarcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(9):2327-35.
2012: Franck bonnetain; Jean-François Bosset; Olivier Bouché; G Calais; O Chapet; T Conroy; J P Gerard; Philippe Maingon; N Methy; Laurent Mineur; Ljiljana Radosevic-Jelic; Laurence Collette
What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: surrogacy in question?
European journal of cancer (Oxford, England : 1990) 2012;48(12):1781-90.
2012: Claire Schvartz; Franck bonnetain; Inna Cochet; Elodie Crevisy; Adèle Cueff; Sandrine Dabakuyo; Audrey Dalac; Sandrine Fieffé; Mélanie Gauthier; Dimitri Papathanassiou; Jean-Marie Pochart; Michel Toubeau
Impact on overall survival of radioactive iodine in low-risk differentiated thyroid cancer patients.
The Journal of clinical endocrinology and metabolism 2012;97(5):1526-35.
2012: Gilles CREHANGE; Melanie Gauthier; Caroline Azelie; Franck bonnetain; Etienne Martin; Celine Mirjolet; Suzanne Naudy; Karine Peignaux-Casasnovas; Gilles Truc; Philippe Maingon
Clinical impact of margin reduction on late toxicity and short-term biochemical control for patients treated with daily on-line image guided IMRT for prostate cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2012;103(2):244-6.
2012: ISABELLE RAY COQUARD; michel salzet; Xavier Sastre-Garau; Sophie Taieb; Charles Theillet; Gwendal Lazennec; Eric Leblanc; Fabrice Lecuru; Frédérique Penault Llorca; Laurent Poulain; Eric Pujade-Lauraine; Patrick Arveux; Franck bonnetain; Christophe Caux; Franck Chauvin; Véronique Christophe; Eric Deutsch; Mojgan Devouassoux; Christine Haie-Meder; Hélène Hoarau; Florence Joly
[PAIR-gynaecology: multi/interdisciplinary for gynecologic cancer research. Problems needed to be resolved].
Bulletin du cancer 2012;99(4):479-98.
2012: Anne-Lise Poirier; Virginie Berger; Jean-Marie Commer; Bénédicte D'Aillières; Fabrice Kwiatkowski; Mariette Mercier; Franck bonnetain
Health-related quality of life in cancer patients at the end of life, translation, validation, and longitudinal analysis of specific tools: study protocol for a randomized controlled trial.
Trials 2012;13():39.
2012: A Attar; Franck bonnetain; Joël Ezenfis; D Laharie; T Lecomte; C Locher; D Malka; J M Sabaté; T Aparicio; J Taieb
Malnutrition is high and underestimated during chemotherapy in gastrointestinal cancer: an AGEO prospective cross-sectional multicenter study.
Nutrition and cancer 2012;64(4):535-42.
2011: Aziz Zaanan; Aimery de Gramont; Peggy Cuilliere-Dartigues; Pierre Validire; Jean-François Fléjou; Françoise Praz; Philippe Rougier; Jean-François Emile; Christophe Louvet; Franck bonnetain; David Malka; Guetz Gaëtan Des; Cédric Lecaille; Julien Taïeb
Defective mismatch repair status as a prognostic biomarker of disease-free survival in stage III colon cancer patients treated with adjuvant FOLFOX chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(23):7470-8.
2011: Frédérique Végran; Romain Boidot; Franck bonnetain; Muriel Cadouot; Sandy Chevrier; Sarab Lizard-Nacol
Apoptosis gene signature of Survivin and its splice variant expression in breast carcinoma.
Endocrine-related cancer 2011;18(6):783-92.
2011: Gilles CREHANGE; Melanie Gauthier; Philippe Maingon; Celine Mirjolet; Sebastien Parfait; Franck bonnetain; Francois Brunotte; Alexandre Cochet; Luc Cormier; Paul Walker
Early choline levels from 3-tesla MR spectroscopy after exclusive radiation therapy in patients with clinically localized prostate cancer are predictive of plasmatic levels of PSA at 1 year.
International journal of radiation oncology, biology, physics 2011;81(4):e407-13.
2011: E Brain; R Delva; B Asselain; Franck bonnetain; M Gauthier; M Jimenez; C Levy; A L Martin; L Mauriac; M Rios; H Roché; D Serin; M Spielmann; C Veyret; Pierre Fumoleau
High rate of extra-haematological toxicity compromises dose-dense sequential adjuvant chemotherapy for breast cancer.
British journal of cancer 2011;105(10):1480-6.
2011: Benoist Chibaudel; Carmen J Allegra; Franck bonnetain; Marc Buyse; Richard M Goldberg; Daniel J Sargent; Qian Shi; Christophe Tournigand; Aimery de Gramont
Alternative end points to evaluate a therapeutic strategy in advanced colorectal cancer: evaluation of progression-free survival, duration of disease control, and time to failure of strategy--an Aide et Recherche en Cancerologie Digestive Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(31):4199-204.
2011: Hedia Brixi-Benmansour; Laurent Bedenne; Franck bonnetain; Olivia Hentic; Jean-Louis Jouve; Bruno Landi; Emmanuel Mitry; Guillaume Cadiot
Phase II study of first-line FOLFIRI for progressive metastatic well-differentiated pancreatic endocrine carcinoma.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2011;43(11):912-6.
2011: Mathieu Boulin; Jean-Pierre Cercueil; Bruno Chauffert; Anne Ciboulet; Alice Gagnaire; Boris Guiu; Patrick Hillon; Denis Krause; Côme Lepage; Emilie Maillard; Anne Minello; Laurent Bedenne; Franck bonnetain; Jean Louis Jouve
Randomised controlled trial of lipiodol transarterial chemoembolisation with or without amiodarone for unresectable hepatocellular carcinoma.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2011;43(11):905-11.
2011: Zeinab Hamidou; Tienhan Sandrine Dabakuyo; Franck bonnetain
Impact of response shift on longitudinal quality-of-life assessment in cancer clinical trials.
Expert review of pharmacoeconomics & outcomes research 2011;11(5):549-59.
2011: Vincenzo Valentini; Ruud G P M van Stiphout; Guido Lammering; Bruce D Minsky; Claus Rödel; Aldo Sainato; Rolf Sauer; Maria Cristina Barba; M Bebenek; Franck bonnetain; Jean-Francois Bosset; Krzysztof Bujko; Luca Cionini; Laurence Collette; Maria Antonietta Gambacorta; Jean-Pierre Gerard; Philippe Lambin
Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(23):3163-72.
2011: Athanasios G Pallis; B Penninckx; L Repetto; A Ring; A Timmer-Bonte; M C Van Nes; G Vonminckwitz; U Wedding; H Wildiers; L Wyld; M Aapro; Franck bonnetain; C Fortpied; C D Johnson; A Luciani
EORTC workshop on clinical trial methodology in older individuals with a diagnosis of solid tumors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(8):1922-6.
2011: Gilles CREHANGE; Mathilde Funes De La Vega; Mélanie Liegard; Philippe Maingon; Céline Mirjolet; Sébastien Parfait; Douraïed Ben Salem; Franck bonnetain; François Brunotte; Alexandre Cochet; Luc Cormier; Paul M Walker
Tumor volume and metabolism of prostate cancer determined by proton magnetic resonance spectroscopic imaging at 3T without endorectal coil reveal potential clinical implications in the context of radiation oncology.
International journal of radiation oncology, biology, physics 2011;80(4):1087-94.
2011: Sylvain Ladoire; Francois Martin; Grégoire Mignot; Cédric Rébé; André Vanoli; Lionel Apetoh; Laurent Arnould; Marie Hélène Bizollon; Franck bonnetain; Bruno Coudert; Charles Coutant; Sandrine Dabakuyo; Pierre Fumoleau; François Ghiringhelli
In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival.
The Journal of pathology 2011;224(3):389-400.
2011: M Barhoumi; L Bedenne; Franck bonnetain; J-F Bosset; O Bouché; J Butel; P Hammel; P Maingon; C Mariette; L Mineur; F Mornex; P Rougier; Noël Stremsdoerfer; T Aparicio; A Azzedine; B Chauffert
[Locally advanced unresectable pancreatic cancer: Induction chemoradiotherapy followed by maintenance gemcitabine versus gemcitabine alone: Definitive results of the 2000-2001 FFCD/SFRO phase III trial].
Cancer radiothérapie : journal de la Société française de radiothérapie oncologique 2011;15(3):182-91.
2011: Luc Taillandier; I-C Thomas; V Bernier; M Blonski; Franck bonnetain; F Bourdeaut; C Carrie; P Chastagner; F Dhermain; F-L Donadey; F Doz; D Frappaz; J Grill; Rémy Guillevin; A Idbaih; A Jouvet; C Kerr; L Padovani; Johan Pallud; Marie-Pierre Sunyach
[Medulloblastomas: review].
Revue neurologique 2011;167(5):431-48.
2011: Aziz Zaanan; Mélanie Gauthier; David Malka; Christophe Locher; Jean-Marc Gornet; Anne Thirot-Bidault; david tougeron; Julien Taïeb; Franck bonnetain; Thomas Aparicio
Second-line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first-line platinum-based chemotherapy: a multicenter AGEO study.
Cancer 2011;117(7):1422-8.
2011: C Rotonda; F Guillemin; Franck bonnetain; T Conroy
Factors correlated with fatigue in breast cancer patients before, during and after adjuvant chemotherapy: the FATSEIN study.
Contemporary clinical trials 2011;32(2):244-9.
2011: Maximilien Barret; Franck bonnetain; Cécile Dalban; Christophe Locher; Samy Louafi; David Malka; Touraj Mansourbakht; Jean-Marc Sabate; Thomas Aparicio; Alain Attar; Julien Taieb
Nutritional status affects treatment tolerability and survival in metastatic colorectal cancer patients: results of an AGEO prospective multicenter study.
Oncology 2011;81(5-6):395-402.
2011: Zeinab Hamidou; Catherine Loustalot; Mariette Mercier; Marie-Martine Padeano; Christian Rosburger; Jean-Marc Sauzedde; Marc Smail; Hervé Tixier; Sylvain Causeret; Patrick Chevillote; Jean-Philibert Combier; Jean Cuisenier; Tienhan S Dabakuyo; Jean Fraisse; Patrick Arveux; Franck bonnetain
Time to deterioration in quality of life score as a modality of longitudinal analysis in patients with breast cancer.
The oncologist 2011;16(10):1458-68.
2011: Benoist Chibaudel; Thierry André; Pascal Artru; Leila Bengrine-Lefevre; Franck bonnetain; Jérôme Desramé; Annette K Larsen; Christophe Louvet; Luis Teixeira; Christophe Tournigand; Aimery de Gramont
Simplified prognostic model in patients with oxaliplatin-based or irinotecan-based first-line chemotherapy for metastatic colorectal cancer: a GERCOR study.
The oncologist 2011;16(9):1228-38.
2011: Nicolas Briez; Cécile Brigand; Nicolas Carrere; Denis Collet; Christophe Doddoli; Renaud Flamein; Jean-Yves Mabrut; Bernard Meunier; Simon Msika; Thierry Perniceni; Frédérique Peschaud; Guillaume Piessen; Michel Prudhomme; Jean-Pierre Triboulet; Franck bonnetain; Christophe Mariette
Open versus laparoscopically-assisted oesophagectomy for cancer: a multicentre randomised controlled phase III trial - the MIRO trial.
BMC cancer 2011;11():310.
2011: Sylvain Ladoire; Franck bonnetain; Mélanie Gauthier; Sylvie Zanetta; Jean Michel Petit; Séverine Guiu; Isabelle Kermarrec; Eric Mourey; Frederic Michel; Denis Krause; Patrick Hillon; Luc Cormier; François Ghiringhelli; Boris Guiu
Visceral fat area as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with antiangiogenic agents.
The oncologist 2011;16(1):71-81.
2011: Caroline Tournoux-Facon; Xavier Paoletti; Jean-Claude Barbare; Olivier Bouché; Philippe Rougier; Laetitia Dahan; Catherine Lombard-Bohas; Roger Faroux; Jean Luc Raoul; Laurent Bedenne; Franck bonnetain
Development and validation of a new prognostic score of death for patients with hepatocellular carcinoma in palliative setting.
Journal of hepatology 2011;54(1):108-14.
2010: A-L Poirier; J-M Commer; F Kwiatkowski; M Mercier; Franck bonnetain
[Oncology blood transfusion and quality of life: review].
Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 2010;17(5-6):357-61.
2010: Laetitia Dahan; Franck bonnetain; Marc Ychou; Emmanuel Mitry; Mohamed Gasmi; Jean-Luc Raoul; Stéphane Cattan; Jean-Marc Phelip; Pascal Hammel; Bruno Chauffert; Pierre Michel; Jean-Louis Legoux; Philippe Rougier; Laurent Bedenne; Jean-François Seitz
Combination 5-fluorouracil, folinic acid and cisplatin (LV5FU2-CDDP) followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: final results of a randomised strategic phase III trial (FFCD 0301).
Gut 2010;59(11):1527-34.
2010: S Guiu; M Gauthier; Bruno Coudert; Franck bonnetain; L Favier; Sylvain Ladoire; H Tixier; Boris Guiu; F Penault-Llorca; F Ettore; Pierre Fumoleau; L Arnould
Pathological complete response and survival according to the level of HER-2 amplification after trastuzumab-based neoadjuvant therapy for breast cancer.
British journal of cancer 2010;103(9):1335-42.
2010: Philippe Maingon; Gilles CREHANGE; Franck bonnetain; A Ligey-Bartolomeu; J Chamois; Y Bruchon; P Romanet; Gilles Truc
[Quality of life for patients treated for head and neck carcinoma].
Cancer radiothérapie : journal de la Société française de radiothérapie oncologique 2010;14(6-7):526-9.
2010: Franck bonnetain; Laetitia Dahan; Emilie Maillard; Marc Ychou; Emmanuel Mitry; Pascal Hammel; Jean-Louis Legoux; Philippe Rougier; Laurent Bedenne; Jean-François Seitz
Time until definitive quality of life score deterioration as a means of longitudinal analysis for treatment trials in patients with metastatic pancreatic adenocarcinoma.
European journal of cancer (Oxford, England : 1990) 2010;46(15):2753-62.
2010: Franck bonnetain
[Health related quality of life and endpoints in oncology].
Cancer radiothérapie : journal de la Société française de radiothérapie oncologique 2010;14(6-7):515-8.
2010: A Zaanan; L Costes; M Gauthier; D Malka; C Locher; E Mitry; D Tougeron; T Lecomte; J-M Gornet; I Sobhani; V Moulin; P Afchain; J Taïeb; Franck bonnetain; T Aparicio
Chemotherapy of advanced small-bowel adenocarcinoma: a multicenter AGEO study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(9):1786-93.
2010: G Crehange; Franck bonnetain; K Peignaux; G Truc; N Blanchard; P Rat; B Chauffert; F Ghiringhelli; P Maingon
Preoperative radiochemotherapy for resectable localised oesophageal cancer: a controversial strategy.
Critical reviews in oncology/hematology 2010;75(3):235-42.
2010: E De Gournay; Franck bonnetain; H Tixier; C Loustalot; S Dabakuyo; Jean Cuisenier
Evaluation of quality of life after breast reconstruction using an autologous latissimus dorsi myocutaneous flap.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2010;36(6):520-7.
2010: Hervé Tixier; Jean Fraisse; Bruno Chauffert; Françoise Mayer; Sylvain Causeret; Catherine Loustalot; Coralie Deville; Franck bonnetain; Paul Sagot; Serge Douvier; Jean Cuisenier
Evaluation of pelvic posterior exenteration in the management of advanced-stage ovarian cancer.
Archives of gynecology and obstetrics 2010;281(3):505-10.
2010: Boris Guiu; Jean Michel Petit; Franck bonnetain; Sylvain Ladoire; Séverine Guiu; Jean-Pierre Cercueil; Denis Krausé; Patrick Hillon; Christophe Borg; Bruno Chauffert; François Ghiringhelli
Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer.
Gut 2010;59(3):341-7.
2010: N Methy; Laurent Bedenne; T Conroy; O Bouché; O Chapet; M Ducreux; J-P Gérard; Franck bonnetain
Surrogate end points for overall survival and local control in neoadjuvant rectal cancer trials: statistical evaluation based on the FFCD 9203 trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(3):518-24.
2010: Zeinab Hamidou; Sylvain Causeret; Tienhan S Dabakuyo; Julie Gentil; Laurent Arnould; Patrick Roignot; Thierry Altwegg; Marie-Laure Poillot; Franck bonnetain; Patrick Arveux
Population-based study of ovarian cancer in Côte d'Or: prognostic factors and trends in relative survival rates over the last 20 years.
BMC cancer 2010;10():622.
2010: Nicolas Methy; Laurent Bedenne; Franck bonnetain
Surrogate endpoints for overall survival in digestive oncology trials: which candidates? A questionnaires survey among clinicians and methodologists.
BMC cancer 2010;10():277.
2009: Laetitia Dahan; Franck bonnetain; Philippe Rougier; Jean-Luc Raoul; Eric Gamelin; Pierre-Luc Etienne; Guillaume Cadiot; Emmanuel Mitry; Denis Smith; Frédérique Cvitkovic; Bruno Coudert; Floriane Ricard; Laurent Bedenne; Jean-François Seitz
Phase III trial of chemotherapy using 5-fluorouracil and streptozotocin compared with interferon alpha for advanced carcinoid tumors: FNCLCC-FFCD 9710.
Endocrine-related cancer 2009;16(4):1351-61.
2009: Catherine Lejeune; Christine Binquet; Franck bonnetain; Amel Mahboubi; Michal Abrahamowicz; Thierry Moreau; Maria Raikou; Laurent Bedenne; Catherine Quantin; Claire Bonithon-Kopp
Estimating the cost related to surveillance of colorectal cancer in a French population.
The European journal of health economics : HEPAC : health economics in prevention and care 2009;10(4):409-19.
2009: T S Dabakuyo; J Fraisse; S Causeret; S Gouy; M-M Padeano; C Loustalot; J Cuisenier; J-M Sauzedde; M Smail; J-P Combier; P Chevillote; C Rosburger; S Boulet; P Arveux; Franck bonnetain
A multicenter cohort study to compare quality of life in breast cancer patients according to sentinel lymph node biopsy or axillary lymph node dissection.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(8):1352-61.
2009: Jean-Claude Barbare; Olivier Bouché; Franck bonnetain; Laetitia Dahan; Catherine Lombard-Bohas; Roger Faroux; Jean-Luc Raoul; Stéphane Cattan; Alain Lemoine; Jean-Frédéric Blanc; Jean-Pierre Bronowicki; Jean-Pierre Zarski; Sophie Cazorla; Dany Gargot; Thierry Thevenot; Emmanuel Diaz; Anne Bastie; Thomas Aparicio; Laurent Bedenne
Treatment of advanced hepatocellular carcinoma with long-acting octreotide: a phase III multicentre, randomised, double blind placebo-controlled study.
European journal of cancer (Oxford, England : 1990) 2009;45(10):1788-97.
2009: Boris Guiu; Cédric Colin; Jean-Pierre Cercueil; Romaric Loffroy; Séverine Guiu; Emmanuelle Ferrant; Jean-Louis Jouve; Franck bonnetain; Mathieu Boulin; François Ghiringhelli; Anne Minello; Patrick Hillon; Laurent Bedenne; Denis Krause; Bruno Chauffert
Pilot study of transarterial chemoembolization with pirarubicin and amiodarone for unresectable hepatocellular carcinoma.
American journal of clinical oncology 2009;32(3):238-44.
2009: C Lejeune; C Binquet; Franck bonnetain
[Conducting a cost-effectiveness trial in oncology: justification and method].
Bulletin du cancer 2009;96(5):603-7.
2009: N Methy; L Bedenne; Franck bonnetain
[Validation of surrogate endpoints in digestive oncology].
Bulletin du cancer 2009;96(5):591-5.
2008: Andrew Kramar; Franck bonnetain; Simone Mathoulin-Pélissier
[Role of the methodology in cluster randomized trials].
Bulletin du cancer 2008;95(12):1141-2.
2008: Sabrina Leclercq; Jérémy Skrzypski; Anne Courvoisier; Catherine Gondcaille; Franck bonnetain; Agnès André; Jean-Michel Chardigny; S Bellenger; Jerome Bellenger; Michel Narce; Stéphane Savary
Effect of dietary polyunsaturated fatty acids on the expression of peroxisomal ABC transporters.
Biochimie 2008;90(10):1602-7.
2008: B Chauffert; F Mornex; Franck bonnetain; P Rougier; C Mariette; O Bouché; J F Bosset; T Aparicio; L Mineur; A Azzedine; P Hammel; J Butel; N Stremsdoerfer; P Maingon; L Bedenne
Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(9):1592-9.
2008: G Créhange; Franck bonnetain; B Chauffert; P Rat; L Bedenne; P Maingon
[Resectable adenocarcinoma of the oesophagogastric junction care: which perioperative treatment?].
Cancer radiothérapie : journal de la Société française de radiothérapie oncologique 2008;12(5):365-73.
2008: Anne-Marie Bouvier; Valérie Jooste; Franck bonnetain; Vanessa Cottet; Marie-Hélène Bizollon; Marie-Pierre Bernard; Jean Faivre
Adjuvant treatments do not alter the quality of life in elderly patients with colorectal cancer: a population-based study.
Cancer 2008;113(4):879-86.
2008: Simone Mathoulin-Pelissier; Sophie Gourgou-Bourgade; Franck bonnetain; Andrew Kramar
Survival end point reporting in randomized cancer clinical trials: a review of major journals.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(22):3721-6.
2008: Franck bonnetain; Xavier Paoletti; Sandra Collette; Michel Doffoel; Olivia Bouché; Jean Luc Raoul; Philippe Rougier; Fadil Masskouri; Jean-Claude Barbare; Laurent Bedenne
Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: results from two French clinical trials.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2008;17(6):831-43.
2008: S Collette; Franck bonnetain; X Paoletti; M Doffoel; O Bouché; J L Raoul; P Rougier; F Masskouri; L Bedenne; J C Barbare
Prognosis of advanced hepatocellular carcinoma: comparison of three staging systems in two French clinical trials.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(6):1117-26.
2008: Christine Rotonda; T Conroy; M Mercier; Franck bonnetain; L Uwer; J Miny; P Montcuquet; I Léonard; A Adenis; G Breysacher; F Guillemin
Validation of the French version of the colorectal-specific quality-of-life questionnaires EORTC QLQ-CR38 and FACT-C.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2008;17(3):437-45.
2008: M Doffoël; Franck bonnetain; O Bouché; Denis Vetter; A Abergel; S Fratté; J D Grangé; N Stremsdoerfer; A Blanchi; Jean-Pierre Bronowicki; F X Caroli-Bosc; X Causse; F Masskouri; P Rougier; L Bedenne
Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Fédération Francophone de Cancérologie Digestive 9402).
European journal of cancer (Oxford, England : 1990) 2008;44(4):528-38.
2008: T S Dabakuyo; Franck bonnetain; P Roignot; M-L Poillot; Gilles Chaplain; T Altwegg; Guy Hedelin; Patrick Arveux
Population-based study of breast cancer survival in Cote d'Or (France): prognostic factors and relative survival.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(2):276-83.
2008: J Gentil-Brevet; Marc Colonna; Arlette Danzon; Pascale Grosclaude; Gilles Chaplain; Michel Velten; Franck bonnetain; Patrick Arveux
The influence of socio-economic and surveillance characteristics on breast cancer survival: a French population-based study.
British journal of cancer 2008;98(1):217-24.
2007: Etienne Martin; Coralie Deville; Franck bonnetain; Mathieu Bosset; Gilles CREHANGE; Gilles Truc; Suzanne Naudy; Philippe Maingon
Intensity-modulated radiation therapy in head and neck cancer: prescribed dose, clinical challenges and results.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2007;85(3):392-8.
2007: Gilles CREHANGE; Philippe Maingon; Karine Peignaux; Tan Dat N'guyen; Xavier Mirabel; Christian Marchal; Pierre Verrelle; Bernard Roullet; Franck bonnetain; Laurent Bedenne
Phase III trial of protracted compared with split-course chemoradiation for esophageal carcinoma: Federation Francophone de Cancerologie Digestive 9102.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(31):4895-901.
2007: Fabien Gueugnon; Catherine Gondcaille; S Leclercq; Jerome Bellenger; S Bellenger; Michel Narce; Thierry Pineau; Franck bonnetain; Stéphane Savary
Dehydroepiandrosterone up-regulates the Adrenoleukodystrophy-related gene (ABCD2) independently of PPARalpha in rodents.
Biochimie 2007;89(11):1312-21.
2007: Claire Oudin; Franck bonnetain; Romain Boidot; Frédérique Végran; Marie-Sophie Soubeyrand; Laurent Arnould; Jean-Marc Riedinger; Sarab Lizard-Nacol
Patterns of loss of heterozygosity in breast carcinoma during neoadjuvant chemotherapy.
International journal of oncology 2007;30(5):1145-51.
2007: Jean-Marc Riedinger; Franck bonnetain; Jean-Pierre Basuyau; N Eche; H Larbre; I Dalifard; J Wafflart; G Ricolleau; Marie-France Pichon
Change in CA 125 levels after the first cycle of induction chemotherapy is an independent predictor of epithelial ovarian tumour outcome.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(5):881-5.
2007: Laurent Bedenne; Pierre Michel; Olivier Bouché; Chantal Milan; Christophe Mariette; Thierry Conroy; Denis Pezet; Bernard Roullet; Jean-François Seitz; Jean-Philippe Herr; Bernard Paillot; Patrick Arveux; Franck bonnetain; Christine Binquet
Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(10):1160-8.
2006: Frédérique Végran; Romain Boidot; Claire Oudin; Jean-Marc Riedinger; Franck bonnetain; Sarab Lizard-Nacol
Overexpression of caspase-3s splice variant in locally advanced breast carcinoma is associated with poor response to neoadjuvant chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(19):5794-800.
2006: Jean-Pierre Gérard; Thierry Conroy; Franck bonnetain; Olivier Bouché; Olivier Chapet; Marie-Thérèse Closon-Dejardin; Michel Untereiner; Bernard Leduc; Eric Francois; Jean Maurel; Jean-François Seitz; Bruno Buecher; Rémy Mackiewicz; Michel Ducreux; Laurent Bedenne
Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(28):4620-5.
2006: Laurent Benoit; Patrick Favoulet; Pablo Ortega Deballon; Nicolas Cheynel; Anisoara Anusca; Diane Bamourou; Franck bonnetain; Patrick Rat; Jean Pierre Favre; Bruno Chauffert
Attempts to improve locoregional chemotherapy for the prevention of colonic cancer liver metastasis in the rat.
Gastroentérologie clinique et biologique 2006;30(8-9):1019-25.
2006: Franck bonnetain; Olivier Bouché; P Michel; C Mariette; Thierry Conroy; Denis Pezet; Bernard Roullet; Jean-François Seitz; Bernard Paillot; Patrick Arveux; Chantal Milan; Laurent Bedenne
A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(5):827-34.
2006: Laurent Arnould; M Gelly; F Penault-Llorca; Laurent Benoit; Franck bonnetain; Claude J Migeon; V Cabaret; V Fermeaux; P Bertheau; J Garnier; Jean-François Jeannin; Bruno Coudert
Trastuzumab-based treatment of HER2-positive breast cancer: an antibody-dependent cellular cytotoxicity mechanism?
British journal of cancer 2006;94(2):259-67.
2005: Franck bonnetain; Olivier Bouché; Thierry Conroy; Patrick Arveux; Jean-Luc Raoul; Marc Giovannini; Pierre-Luc Etienne; Emmanuel Mitry; Jean-François Seitz; Philippe Rougier; Cécile Girault; Laurent Bedenne
Longitudinal quality of life study in patients with metastatic gastric cancer. Analysis modalities and clinical applicability of QoL in randomized phase II trial in a digestive oncology.
Gastroentérologie clinique et biologique 2005;29(11):1113-24.
2005: Jean-Claude Barbare; Olivier Bouché; Franck bonnetain; Jean-Luc Raoul; Philippe Rougier; Armand Abergel; Valérie Boige; Bernard Denis; Alain Blanchi; Alexandre Pariente; Chantal Milan; Laurent Bedenne
Randomized controlled trial of tamoxifen in advanced hepatocellular carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(19):4338-46.
2004: Olivier Bouché; Jean-Luc Raoul; Franck bonnetain; Marc Giovannini; Pierre-Luc Etienne; Gérard Lledo; Dominique Arsène; Jean Francois Paitel; Véronique Guérin-Meyer; Emmanuel Mitry; Bruno Buecher; Marie Christine Kaminsky; Jean-François Seitz; Philippe Rougier; Laurent Bedenne; Chantal Milan
Randomized multicenter phase II trial of a biweekly regimen of fluorouracil and leucovorin (LV5FU2), LV5FU2 plus cisplatin, or LV5FU2 plus irinotecan in patients with previously untreated metastatic gastric cancer: a Federation Francophone de Cancerologie Digestive Group Study--FFCD 9803.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(21):4319-28.
2004: Juliette Thariat; Y Bruchon; Franck bonnetain; Isabelle Barillot; Gilles Truc; Karine Peignaux; Jean-Claude Horiot; Philippe Maingon
Conservative treatment of early glottic carcinomas with exclusive radiotherapy.
Cancer radiothérapie : journal de la Société française de radiothérapie oncologique 2004;8(5):288-96.
2004: M Baumann; Franck bonnetain; S Briançon; francois alla
Quality of life and attitudes towards psychotropics and dependency: consumers vs. non-consumers aged 50 and over.
Journal of clinical pharmacy and therapeutics 2004;29(5):405-15.